MyFinsight
Home
Blog
About
Contact
Download
Download image
Net increase
(decrease) in cash
-$1,748,706
Accounts payable and
accrued expenses
$448,494
Stock-based compensation -
stock options
$42,674
Accrued interest
expense - related...
$6,301
Depreciation expense of
property and equipment
$1,489
Accretion expense
$1
Net cash used in
operating activities
-$1,726,166
Net cash provided by
investing activities
-$22,540
Canceled cashflow
$498,959
Net loss
-$1,781,255
Purchase of furniture and
equipment
$22,540
Prepaid expenses and
other current and...
$431,011
Change in fv of warrant
liability
-$12,859
Back
Back
Cash Flow
source: myfinsight.com
Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. (APUS)